Effects of Dezocine and Sufentanil on Th1/Th2 Balance in Breast Cancer Patients Undergoing Surgery
Xudong Hu,Bing Luo,Qing Wu,Qingbiao Chen,Penghui Lu,Jie Huang,Xiaoxia Liang,Cheng Ling,Yiqun Li
DOI: https://doi.org/10.2147/DDDT.S326891
2021-12-02
Abstract:Xudong Hu, 1, &ast Bing Luo, 2, &ast Qing Wu, 2 Qingbiao Chen, 2 Penghui Lu, 2 Jie Huang, 3 Xiaoxia Liang, 1 Cheng Ling, 1 Yiqun Li 2 1 Department of Anesthesiology, The Second People's Hospital of Foshan, Foshan, Guangdong, 528000, People's Republic of China; 2 Department of Surgery, The Second People's Hospital of Foshan, Foshan, Guangdong, 528000, People's Republic of China; 3 Clinical Laboratory, The Second People's Hospital of Foshan, Foshan, Guangdong, 528000, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yiqun Li Department of Surgery, The Second People's Hospital of Foshan, No. 78 Weiguo Road, Foshan, Guangdong, 528000, People's Republic of China Tel +86 13902845621 Fax +86 75788032008 Email Background: It is very important for breast cancer patients undergoing surgery to choose an opioid that has little effect on the immune system. The aim of this study is to compare the effects of dezocine or sufentanil on postoperative pain and Th1/Th2 balance in patients undergoing breast cancer surgery. Methods: Data from 92 breast cancer patients from January 2019 to July 2020 at Foshan Second People's Hospital (Guangdong, China) were analyzed. Sufentanil (SF) was used in group SF (n = 44) and dezocine (DE) in group DE (n = 48). The Visual Analog Scale (VAS) scores were assessed, and the percentages of Th1 cells and Th2 cells in peripheral blood were detected before anesthesia and at 2, 12, 24, and 48 hours after surgery. Results: There was no significant difference in the VAS scores between the two groups at 2, 24, and 48 hours after surgery (P > 0.05). The VAS scores at 12 hours after surgery in group DE were significantly lower than those in group SF with a statistically significant difference (P < 0.05). The percentage of Th1 cells in group DE at 2, 12, 24, and 48 hours after surgery was significantly lower than that in group SF (P < 0.05). The percentage of Th2 cells in group DE at 2, 12, 24, and 48 hours after surgery was significantly lower than that in group SF (P < 0.05). The Th1/Th2 ratio at 2, 12, 24, and 48 hours after surgery was significantly higher in group DE than that in group SF (P < 0.05). Conclusion: Dezocine for anesthesia induction and postoperative analgesia can maintain the balance of Th1/Th2 more stable than, with the same analgesia efficacy as, sufentanil during the early postoperative period in breast cancer patients undergoing surgery. Keywords: dezocine, sufentanil, VAS, Th1/Th2 balance, breast cancer Breast cancer is the most common malignant tumor in women, and its global morbidity has recently increased at a rate of over 2 million per year. 1,2 Surgery is the main treatment for breast cancer, but postoperative recurrence and metastasis are still the leading causes of death in breast cancer patients, though neoadjuvant therapy improves the tumor-free survival and overall survival in patients with breast cancer. 2,3 The immunity of cancer patients, especially cellular immunity, plays a vital role in the body's antitumor defense mechanisms. 4–6 The stress response caused by surgery and postoperative pain may induce the release of certain hormones and cytokines that are mediated by the sympathetic nervous system and the hypothalamic–pituitary–adrenal axis. 4–6 which may cause immunosuppression in which the Th1/Th2 balance shifts toward the Th2 phenotype. 7,8 Furthermore, nociceptive stimuli such as pain are also involved in immune regulation through the signaling pathways in the central nervous system. Therefore, opioids should be used perioperatively in anesthesia and analgesia to reduce the stress response and alleviate pain, and, especially for cancer patients, to maintain normal immunity. 4–7 But the well-known side effects of opioids, suppression of the immune system has been increasingly reported, and the concern that their immunological effects during and after surgery may impact disease processes, especially cancer, has increased proportionally. 4,5 T helper cell (Th cell) is the key regulator of host in anti-tumour immunity and its specialized subsets are generated following activation through lineage-specifying cytokines and transcriptional programs, such as T-bet and GATA3 8,9 in which differentiation of Th1 cells is promoted by the cytokine IL-12, while IL-4 drives Th2 cell differentiation. These cytokines influence each other, in which the balance of Th1/Th2 was maintained stable and the body immunity is in normal. 6,7 Th1 cells and Th2 cells were first resign -Abstract Truncated-